{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T18:20:45Z","timestamp":1792866045380,"version":"4.5.0"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/bor.0b013e32835f693f","type":"journal-article","created":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T02:27:58Z","timestamp":1362104878000},"page":"360-366","source":"Crossref","is-referenced-by-count":97,"title":["Extra-articular rheumatoid arthritis"],"prefix":"10.1097","volume":"25","author":[{"given":"Carl","family":"Turesson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/BOR.0b013e32831c5303","article-title":"Vasculitis in rheumatoid arthritis.","volume":"21","author":"Turesson","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"R3-12-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2011.09.001","article-title":"Extra-articular manifestations of rheumatoid arthritis: an update.","volume":"11","author":"Prete","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R4-12-20210128","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00002281-200405000-00007","article-title":"Management of extra-articular disease manifestations in rheumatoid arthritis.","volume":"16","author":"Turesson","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(73)90040-5","article-title":"The extra-articular features of rheumatoid arthritis: a systematic analysis of 127 cases.","volume":"54","author":"Gordon","year":"1973","journal-title":"Am J Med"},{"key":"R7-12-20210128","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/ard.2005.039172","article-title":"Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis.","volume":"65","author":"Nyhall-Wahlin","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R8-12-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03009740310004621","article-title":"Epidemiology of extra-articular manifestations in rheumatoid arthritis.","volume":"33","author":"Turesson","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"R9-12-20210128","first-page":"179","article-title":"Clustering of extraarticular manifestations in patients with rheumatoid arthritis.","volume":"35","author":"Turesson","year":"2008","journal-title":"J Rheumatol"},{"key":"R10-12-20210128","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/030097400447552","article-title":"Predictors of extra-articular manifestations in rheumatoid arthritis.","volume":"29","author":"Turesson","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"R11-12-20210128","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/rheumatology\/kep004","article-title":"High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis.","volume":"48","author":"Nyhall-Wahlin","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R12-12-20210128","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/38.7.668","article-title":"Extra-articular rheumatoid arthritis: prevalence and mortality.","volume":"38","author":"Turesson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"R13-12-20210128","first-page":"62","article-title":"Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis.","volume":"29","author":"Turesson","year":"2002","journal-title":"J Rheumatol"},{"key":"R14-12-20210128","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1002\/art.20590","article-title":"No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study.","volume":"50","author":"Turesson","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R15-12-20210128","first-page":"920","article-title":"Rheumatoid vasculitis: becoming extinct Rheumatology (Oxford","volume":"43","author":"Watts","year":"2004","journal-title":")"},{"key":"R16-12-20210128","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3899\/jrheum.101133","article-title":"Incidence of extraarticular rheumatoid arthritis in Olmsted County Minnesota, in 1995-2007 versus 1985-1994: a population-based study.","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J Rheumatol"},{"key":"R17-12-20210128","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/rheumatology\/keq135","article-title":"Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years.","volume":"49","author":"Bartels","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R18-12-20210128","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.2009.123919","article-title":"Treating rheumatoid arthritis to target: recommendations of an international task force.","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R19-12-20210128","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R20-12-20210128","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R21-12-20210128","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"R22-12-20210128","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/art.20006","article-title":"Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3240 rheumatoid arthritis patients.","volume":"50","author":"Gorman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R23-12-20210128","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1002\/art.20588","article-title":"Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis.","volume":"50","author":"Gorman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R24-12-20210128","doi-asserted-by":"crossref","first-page":"R1386","DOI":"10.1186\/ar1837","article-title":"The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis.","volume":"7","author":"Turesson","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R25-12-20210128","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/art.22057","article-title":"Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis.","volume":"54","author":"Turesson","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R26-12-20210128","first-page":"2287","article-title":"Antitumor necrosis factor-alpha therapy-induced vasculitis: case series.","volume":"30","author":"Jarrett","year":"2003","journal-title":"J Rheumatol"},{"key":"R27-12-20210128","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/03009740410005836","article-title":"Severe interstitial pneumonitis associated with infliximab therapy.","volume":"33","author":"Chatterjee","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"R28-12-20210128","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/rheumatology\/kel090","article-title":"Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment.","volume":"45","author":"Lindsay","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R29-12-20210128","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/03009740601153774","article-title":"Rheumatoid arthritis treatment and the risk of severe interstitial lung disease.","volume":"36","author":"Wolfe","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"R30-12-20210128","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/03009742.2012.695803","article-title":"Extra-articular manifestations in a community-based sample of patients with rheumatoid arthritis: incidence and relationship to treatment with TNF inhibitors.","volume":"41","author":"Nyhall-Wahlin","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"R31-12-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/ard.48.1.7","article-title":"Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study.","volume":"48","author":"Erhardt","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"R32-12-20210128","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/art.10705","article-title":"Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.","volume":"48","author":"Gabriel","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R33-12-20210128","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study.","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R34-12-20210128","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.2006.052506","article-title":"Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis.","volume":"66","author":"Turesson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R35-12-20210128","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/art.10529","article-title":"Predictors of infection in rheumatoid arthritis.","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R36-12-20210128","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/art.27555","article-title":"Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry.","volume":"62","author":"Gottenberg","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R37-12-20210128","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/ard.2006.052803","article-title":"Multiple extra-articular manifestations are associated with poor survival in patients with rheumatoid arthritis.","volume":"65","author":"Turesson","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R38-12-20210128","first-page":"1296","article-title":"Survivorship in a population based cohort of patients with Sjogrens syndrome 1976-1992.","volume":"26","author":"Martens","year":"1999","journal-title":"J Rheumatol"},{"key":"R39-12-20210128","first-page":"405","article-title":"The association of cryoglobulinaemia with nodules, vasculitis and fibrosing alveolitis in rheumatoid arthritis and their relationship to serum C1q binding activity and rheumatoid factor.","volume":"38","author":"Erhardt","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"R40-12-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/art.22310","article-title":"CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis.","volume":"56","author":"Michel","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R41-12-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005792-199069020-00001","article-title":"The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations.","volume":"69","author":"Campion","year":"1990","journal-title":"Medicine (Baltimore)"},{"key":"R42-12-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/ard.50.4.231","article-title":"Characterisation of the size and composition of circulating immune complexes in patients with rheumatoid arthritis.","volume":"50","author":"Mageed","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"R43-12-20210128","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/ard.46.10.727","article-title":"Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications.","volume":"46","author":"Geirsson","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"R44-12-20210128","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/ard.2007.076521","article-title":"Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort.","volume":"66","author":"Turesson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R45-12-20210128","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/art.1780381114","article-title":"Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis: a clinicopathologic and prognostic study of thirty-two patients.","volume":"38","author":"Puechal","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R46-12-20210128","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.55.3.190","article-title":"Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study.","volume":"55","author":"Voskuyl","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"R47-12-20210128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.054445","article-title":"Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis.","volume":"66","author":"Turesson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R48-12-20210128","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/art.21758","article-title":"Morphologic and quantitative assessment of CD20 B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia.","volume":"54","author":"Atkins","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R49-12-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.20765","article-title":"Increased CD4 T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis.","volume":"52","author":"Turesson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R50-12-20210128","doi-asserted-by":"crossref","first-page":"e33133","DOI":"10.1371\/journal.pone.0033133","article-title":"Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope.","volume":"7","author":"Furukawa","year":"2012","journal-title":"PLoS One"},{"key":"R51-12-20210128","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9343(84)90654-5","article-title":"Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis.","volume":"76","author":"Scott","year":"1984","journal-title":"Am J Med"},{"key":"R52-12-20210128","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression.","volume":"91","author":"Foster","year":"1984","journal-title":"Ophthalmology"},{"key":"R53-12-20210128","first-page":"175","article-title":"1958 revision of diagnostic criteria for rheumatoid arthritis.","volume":"9","author":"Ropes","year":"1958","journal-title":"Bull Rheum Dis"},{"key":"R54-12-20210128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"R55-12-20210128","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.2007.081679","article-title":"Antitumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis.","volume":"67","author":"Puechal","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R56-12-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/acr.20689","article-title":"Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: results from the autoimmunity and rituximab registry.","volume":"64","author":"Puechal","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R57-12-20210128","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/01.mcp.0000239552.55326.ee","article-title":"Interstitial lung disease in rheumatoid arthritis: recent advances.","volume":"12","author":"Kim","year":"2006","journal-title":"Curr Opin Pulm Med"},{"key":"R58-12-20210128","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/ard.46.10.757","article-title":"Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease.","volume":"46","author":"Berglund","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"R59-12-20210128","first-page":"518","article-title":"Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis.","volume":"25","author":"Nakamura","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"R60-12-20210128","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.122.3.1093","article-title":"Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition.","volume":"122","author":"Vassallo","year":"2002","journal-title":"Chest"},{"key":"R61-12-20210128","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4049\/jimmunol.170.1.567","article-title":"Repression of bleomycin-induced pneumopathy by TNF.","volume":"170","author":"Kuroki","year":"2003","journal-title":"J Immunol"},{"key":"R62-12-20210128","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/art.23645","article-title":"The controversial role of tumor necrosis factor alpha in fibrotic diseases.","volume":"58","author":"Distler","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R63-12-20210128","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2009.120626","article-title":"Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register.","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R64-12-20210128","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/rheumatology\/39.12.1422","article-title":"Successful use of cyclosporin A for the treatment of acute interstitial pneumonitis associated with rheumatoid arthritis.","volume":"39","author":"Ogawa","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"R65-12-20210128","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/thx.35.10.725","article-title":"Response to methotrexate in fibrosing alveolitis associated with connective tissue disease.","volume":"35","author":"Scott","year":"1980","journal-title":"Thorax"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e32835f693f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:17:35Z","timestamp":1786040255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-201305000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e32835f693f","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}